PRALUENT 150mg solution for injection in pre-filled pen SANOFI
alirocumab Indicated for: dyslipidemia
letter P · page 47
alirocumab Indicated for: dyslipidemia
alirocumab Indicated for: dyslipidemia
alirocumab Indicated for: dyslipidemia
alirocumab Indicated for: dyslipidemia
alirocumab Indicated for: dyslipidemia
ziprasidone Indicated for: schizophrenia; bipolar disorder
N05AE04 Nervous system | Antipsychotics | Indole derivatives
ziprasidone Indicated for: schizophrenia; bipolar disorder
N05AE04 Nervous system | Antipsychotics | Indole derivatives
ziprasidone Indicated for: schizophrenia; bipolar disorder
N05AE04 Nervous system | Antipsychotics | Indole derivatives
ziprasidone Indicated for: schizophrenia; bipolar disorder
N05AE04 Nervous system | Antipsychotics | Indole derivatives
metoclopramide Indicated for: nausea and vomiting
metoclopramide Indicated for: nausea and vomiting
pramipexole Indicated for: Parkinson's disease
N04BC05 Nervous system | Dopaminergic agents | Dopamine agonists
pramipexole Indicated for: Parkinson's disease
N04BC05 Nervous system | Dopaminergic agents | Dopamine agonists
pramipexole Indicated for: Parkinson's disease
N04BC05 Nervous system | Dopaminergic agents | Dopamine agonists
pramipexole Indicated for: Parkinson's disease
N04BC05 Nervous system | Dopaminergic agents | Dopamine agonists
pramipexole Indicated for: Parkinson's disease
N04BC05 Nervous system | Dopaminergic agents | Dopamine agonists
pramipexole Indicated for: Parkinson's disease
N04BC05 Nervous system | Dopaminergic agents | Dopamine agonists
pramipexole Indicated for: Parkinson's disease
N04BC05 Nervous system | Dopaminergic agents | Dopamine agonists
pramipexole Indicated for: Parkinson's disease
N04BC05 Nervous system | Dopaminergic agents | Dopamine agonists
pramipexole Indicated for: Parkinson's disease
N04BC05 Nervous system | Dopaminergic agents | Dopamine agonists